Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Nat Metab 3:142148
if you become pregnant whilst on treatment, stop the medication and seek immediate medical and nutritional review [1] [25] Contact your GP urgently if you experience: Severe, persistent abdominal pain (with or without vomiting) which could indicate pancreatitis Upper-right abdominal pain, fever or jaundice which may suggest gallbladder disease Persistent nausea or vomiting preventing adequate nutrition Signs of dehydration (dark urine, dizziness, reduced urination) Unexplained symptoms such as jaundice, severe fatigue, or mood changes For people with diabetes: hypoglycaemia (low blood sugar) symptoms when taking insulin or sulfonylureas alongside GLP-1 therapy Regular monitoring throughout GLP-1 treatment should include periodic assessment of weight, body composition where possible, nutritional intake, and relevant blood markers
The combination produces greater appetite suppression, better fat loss (especially visceral fat), stronger insulin sensitivity, and improved cardiometabolic markers
The FDA approved liraglutide as Saxenda in 2014 and semaglutide as Wegovy in 2021
US$ 29.13
US$ 28.09
US$ 24.09
US$ 26.37
US$ 22.53
US$ 23.75
US$ 28.97
